Our organizations view medication-assisted treatment (MAT) as an important component of a multipronged approach to addressing opioid abuse and improving treatment. We applaud efforts to expand access to MAT, such as increasing Drug Addiction Treatment Act (DATA) waivered physician’s prescribing caps and allowing nurse practitioners (NPs) and physician assistants (PAs) to obtain a DATA waiver.
Press Release: More than 2,500 managed care pharmacy professionals from across the country gathered in the heart of Texas this week for dozens of educational sessions and discussions on how to boost outcomes and control costs for the roughly 270 million Americans covered by a managed pharmacy benefit.
Press Releases: Four leading health care experts are generally optimistic that the U.S. will successfully address one of the fiercest challenges facing the health care system: paying for often spectacular, but high-cost gene and other curative therapies.
Partnership Forum: Industry leaders convened on October 19, 2017 to discuss this important issue. They found broad consensus on the importance of patient reported outcomes (PRO) in defining value.
Press Release: The perception of what is "valuable" in any particular therapy can vary widely between providers, patients and payers, according to panelists at the Academy of Managed Care Pharmacy (AMCP) Foundation's 7th Annual Research Symposium.